Oral Status of Patients Suffering From SCHIZophrenia Followed at Charles Perrens Hospital
NCT04191200 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51
Last updated 2020-04-30
Summary
The aim of the study is to describe the oral health status of patients suffering from schizophrenia and schizoaffective disorders in a psychiatric institute in France.
Conditions
- Dental Diseases
- Schizophrenia
Sponsors & Collaborators
-
Centre Hospitalier Charles Perrens, Bordeaux
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-24
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- France
Study Locations
More Related Trials
-
Prevalence of Dissociative Disorders in Children
NCT01512641 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Efficacy of a Fatigue Management Therapy in Schizophrenia
NCT04332601 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
COVID-19 and Psychotic Symptoms in France
NCT04356885 ·Status: COMPLETED
-
A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of Illness
NCT01959659 ·Status: COMPLETED
-
Exploration of the Social Cognition in Adolescents With a Dissociative Disorder or Autism Spectrum
NCT01805128 ·Status: COMPLETED ·Phase: NA
-
Liver Status in Psychiatric Inpatients
NCT05213442 ·Status: COMPLETED ·Phase: NA
-
Suicidal Behavior Among Schizophrenic Patients
NCT07145840 ·Status: COMPLETED
-
Prevalence of Cardiovascular Disorders in Patients Aged 40 and More With Schizophrenia
NCT05174533 ·Status: UNKNOWN
-
Study of the Impact on the Therapeutic Alliance of a Short Initial Psychoeducation Programme in Patients With Early Schizophrenia
NCT04867681 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Impact of Cannabis Consumption on Psychotic Symptoms and Reality Monitoring in Patients With Schizophrenia: a Real-life Study
NCT07309159 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Death Number Perception in Depression, Anxiety, and Schizoypal Personnality in General Population (Covid-19 Pandemic)
NCT04384419 ·Status: COMPLETED
-
The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy
NCT01215383 ·Status: UNKNOWN
-
Mental Health During the Whole Life Cycle of Community Patients with Schizophrenia
NCT05159349 ·Status: RECRUITING
-
Effectiveness of an Interactive Educational Website for Improving the Quality of Mental Health Care for People With Schizophrenia
NCT00312949 ·Status: COMPLETED ·Phase: NA
-
Effect of Dietary Fiber Supplement on the Intestinal Microbiota Among Schizophrenia Patients
NCT03552237 ·Status: UNKNOWN ·Phase: NA
-
Mental Healthcare in Older Adults With Schizophrenia
NCT02884739 ·Status: UNKNOWN
-
Cerebral Impact of Cognitive Remediation for People Suffering From Schizophrenia
NCT04033978 ·Status: TERMINATED ·Phase: NA
-
A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia
NCT01490567 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Motivational Therapy on Schizophrenia With Cannabis Misuse
NCT00798109 ·Status: COMPLETED ·Phase: NA
-
Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia
NCT00455702 ·Status: COMPLETED ·Phase: PHASE4
-
Study of CYR-101 in Patients With Schizophrenia
NCT00861796 ·Status: COMPLETED ·Phase: PHASE2
-
Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients
NCT06040944 ·Status: COMPLETED
-
Impact of Cognitive & Metacognitive Performance on Knowledge Learning When Conducting Therapeutic Education Programs
NCT04590300 ·Status: COMPLETED ·Phase: NA
-
Dimensional and Developmental Profiles of Psychosis in Children and Adolescents
NCT04370730 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Membrane Phospholipid and Energy Metabolism in Subjects at High Risk of Psychotic Transition
NCT05865652 ·Status: RECRUITING ·Phase: NA